P
Petlife Pharmaceuticals, Inc. (PTLF)
PNK – Real Time Price. Currency in USD
0.00
0.00 (0.00%)
At close: Sep 9, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
PNK – Real Time Price. Currency in USD
0.00
0.00 (0.00%)
At close: Sep 9, 2026, 4:00 PM EDT
Petlife Pharmaceuticals, Inc. engages in the research, development, sale, and support of drugs and nutraceuticals for pet cancer and autoimmune related diseases, such as arthritis in the United States. The company's principal product is Vitalzul that inhibits blood vessels formation in solid tumors. It is also developing Vitalzul as a prescription strength oral pharmaceutical, as well as a concentrated intravenous and injectable version for direct administration to a tumor. In addition, the company develops edible dog and cat treats. Petlife Pharmaceuticals, Inc. is based in Los Angeles, California.
| Name | Position |
|---|---|
| Dr. Arthur Grant Mikaelian Ph.D. | Founder and Chief Scientific Officer |
| Mr. Sebastian Serrell-Watts | Chairman, CEO, President, CFO, Secretary & Treasurer |
There is no data to display